Specifically, miR-146b was reported to be involved mainly in leukemia, epidermal growth factor receptor (EGFR), MAPK, and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathways (Mathews et al., 2004; Taganov et al., 2006; Xiang et al., 2014). This evidence concerns the gene NFKB1 and leukemia.